CD274 and neoplasm: A recent meta-analysis on biomarker modalities for predicting response to PD-1/PD-L1 checkpoint blockade confirmed that immune cell infiltration is a stronger predictor of response than PD-L1 expression, gene expression profiles or tumor mutational burden (188).